Access pharmaceutical science and medical research
The right research could be the key to your organization’s next discovery
Ensure you have the right content for every stage in the drug discovery pipeline with our extensive portfolio of pharmaceutical science and medical journals.
We work with 100% of the biggest drug companies ranked by Forbes¹ and 43 of the top 50 global pharma companies ranked by Pharmaceutical Executive<.²
With over 375 titles, our medical portfolio supports the work of pharmaceutical researchers, physicians, and healthcare professionals around the world and across multiple therapy areas. Industry leaders publishing with us include GlaxoSmithKline, Johnson & Johnson, Merck, China Resources, Sanofi, Bayer, and more.
How your team benefits
Information. We partner with learned societies and institutions to deliver high-quality, applicable content.
Innovation. With access to just-published studies and breakthroughs, your research group can build on new ideas and advance the discipline.
Join the thousands of researchers and R&D professionals who rely on Taylor & Francis research to inform their work.
Taylor & Francis is a member of the Committee on Publishing Ethics (COPE). All of our peer-reviewed journals are published following COPE guidelines.
Featured industry journals
The cornerstone of our pharma and medical portfolio is the Expert Collection, 28 peer-reviewed journals combining the Expert Opinion and Expert Review series into one comprehensive collection. The Expert Opinion series spans the entire R&D pipeline, from drug discovery to launch, while the Expert Review series covers 17 different areas of clinical medicine.
A few of these key titles are:
- Expert Review of Anticancer Therapy
- Expert Review of Clinical Immunology
- Expert Review of Pharmacoeconomics & Outcomes Research
- Expert Review of Precision Medicine and Drug Development
- Expert Review of Vaccines
- Expert Opinion on Drug Delivery
- Expert Opinion on Drug Discovery
- Expert Opinion on Investigational Drugs
- Expert Opinion on Orphan Drugs
- Expert Opinion on Drug Safety
- Expert Opinion on Emerging Drugs
Leading journals in the pharmaceutical science and medical portfolio also include:
As anticancer immunotherapies continue to advance and are combined with conventional anticancer therapies, OncoImmunology aims to provide high-quality research on all aspects of fundamental and applied tumor immunology.
2019 Impact Factor: 5.869*
Leukemia & Lymphoma
A premier reference source for scientists interested in clinical, translational, and basic science research on all aspects of hematological malignancies.
2019 Impact Factor: 2.969*
Human Vaccines & Immunotherapeutics
The only peer-reviewed journal focused on developments in vaccines and immunotherapy for humans. Topics include experimental vaccines, product safety, pharmacoeconomics, and more. The journal is sponsored by the International Society for Vaccines (ISV).
2019 Impact Factor: 2.619*
Established by Charles Mayo, MD, founder of the Mayo Clinic, this journal publishes research which supports primary care physicians in solving clinical problems and improving patient care.
2019 Impact Factor: 2.464*
Drug Development & Industrial Pharmacy
Publishing original research manuscripts related to pharmaceutical research and development and industrial pharmacy. Topics include pharmaceutical engineering, analytical technologies, regulatory science, and more.
2019 Impact Factor: 2.365*
Current Medical Research and Opinion
An international journal for the publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations.
2019 Impact Factor: 2.271*
Journal of Medical Economics
Serving the international pharmacoeconomics and healthcare-research community, helping to translate research advances into patient care. The journal also publishes studies that determine the effectiveness of medical treatment, involving measurements of therapeutic and/or preventative outcomes.
2019 Impact Factor: 1.958*
An authoritative medical journal covering the latest treatments, protocols, and best practices for treating medically-ill hospitalized patients pre- and post-discharge.
You can find all of our medical and pharmaceutical science research on Taylor & Francis Online.
Looking for research in other industry sectors? Explore more content and get ideas for developing your collection.
¹Forbes Global 2000: The World’s Largest Public Companies, 2019.
²Pharmaceutical Executive’s Top 50 Companies, 2019.
*Copyright: 2019 Journal Citation Reports®, Clarivate Analytics, 2020.
Are you a researcher looking to publish your work? Visit the homepage of your chosen journal on Taylor & Francis Online to find Instructions for Authors.
Taylor & Francis defines our commercial and corporate customers as companies that are private or for-profit. Affiliated with an institution or society? Find contact information here.